Organogenesis

ORGONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$107.894 M

$0.84 -3.62%

Close of 6 Nov 2026

As of 6 Nov 2026, Organogenesis (ORGO) has a market capitalization of $107.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$564.2M

#1834 by revenue

Earnings

$37.0M

#1670 by earnings

Shares outstanding

129,801,720

Latest filing cover page

P/E ratio

2.9

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#283Minerva NeurosciencesNERV$109.8M
#284Kazia TherapeuticsKZIA$109.7M
#285OrganogenesisORGO$107.9M
#286Anixa BiosciencesANIX$105.0M
#287NovaBridge BiosciencesNBP$104.8M

What if Organogenesis were worth as much as…

Open the what-if tool →

Gold $28.2T

$219,444.13

Per share 261,710× higher

Bitcoin $1.53T

$11,873.74

Per share 14,161× higher

Apple $5.02T

$38,980.38

Per share 46,488× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Organogenesis are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.